Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chinese Year Of The Rabbit Expected To Speed Up New Drug Approvals

Feb 01 2011

• By The Pink Sheet Daily

Related Content

3SBIO Sees Slowdown In China Regulatory Approvals Following SFDA Restructure; Concerns Linger On Drug Pricing Examination

Aug 20 2010

3SBio Files For Approval For Interleukin-2 NuLeusin

Nov 23 2008

China Issues Fast-Track Registration Procedure For Drugs To Balance Innovation And Risk: SFDA Press Conference

Jan 12 2009

China's State FDA Steps Up Transparency With First Annual Review Of Drug Approval Process, Outcome

Sep 29 2010

AstraZeneca Healthcare Policy Research VP James Cai On Building A CRO Community In China: An Interview With PharmAsia News

Dec 11 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window